This study reports the molecular characterisation of the bilirubin UDPglucuronosyl-transferase gene (UGT1) in a group of patients of Sardinian descent with Crigler-Najjar syndrome type I and their relatives. Sequence analysis of both UGT1A exon 1 and common exons 2-5 was performed in all patients, leading to the detection of AF170 and a novel mutation (470insT), both residing in UGT1A exon 1. All but two heterozygotes for the AF170 mutation showed normal serum bilirubin levels. These two subjects were also heterozygous for the sequence variation A(TA)7TAA in the promoter region of the UGT1A gene.
Crigler-Najjar (CN) In six relatives of one of the patients investigated (PEd), who were found to be heterozygous for a mutation in the UDP glucuronosyl-transferase gene, we carried out serum total bilirubin determination (STB). The results were normal in all but two, who had been previously diagnosed as affected by Gilbert syndrome (fig 1) .
Mutation analysis
Sequence analysis ofboth the specific exon 1 of UGT1A and the common exons 2-5 in all the five patients showed two mutations in exon 1, the previously described deletion of the phenylalanine codon (TTC) at position 170 (AF170) of UGT1A and a novel mutation, the insertion of a T at codon 158-159 (470insT), which results in a frameshift and in the production of a downstream stop codon (TGA) at position 182 (fig 2) . Of these patients, three unrelated ones were homozygotes for AF1 70 and two sibs were compound heterozygotes for AF170 and 470insT. Of the 10 chromosomes carrying a defective UGT1A gene, eight thus contained the AF170 mutation. The AF170 mutation may be easily detected by electrophoretic separation of a 401 bp DNA fragment containing the mutation on a 2 mol/l urea, 6% polyacrylamide gel. The 401 bp fragment was amplified with forward primer zygous for the AF170 mutation, were investigated for the A(TA)7TAA nt variation. Only the two subjects with increased STB concentration in this group showed heterozygosity for A(TA)7TAA, the others being homozygous for A(TA)6TAA.
Discussion
In this study, we have characterised the molecular defect in the bilirubin UDPglucuronosyl transferase gene in five patients affected by Crigler-Najjar syndrome type I belonging to four families of Sardinian origin. We found three patients homozygous for a previously described mutation, the deletion of the phenylalanine codon at position 170 (AF 170) of exon 1 of UGT1A, and two patients from the same family compound heterozygous for AF170 and a novel mutation consisting of the insertion of a T at codon 158-159 (470insT) of exon 1 of UGT1A.
The AF170 mutation has been previously described in a single patient of caucasian orgin." This mutation abolishes a conserved diphenylalanine at this position and results in the production of one third level of mRNA and presumably mutant protein as compared to the wild type gene. Furthermore, the mutant protein has no enzymatic activity at low pH (6.4), which is the optimum pH for bilirubin glucuronidation.
The 470insT mutation results in a frameshift and downstream stop codon, thus probably leading to absent protein product or to the production of a shortened functionless protein.
Both mutations detected in this study reside in the specific exon 1 of UGT1A. This finding is consistent with the notion that UGT1A codes for the only relevant enzymatic isoform in bilirubin glucuronidation.
It is interesting to note that seven of eight mutant alleles from unrelated patients of Sardinian ancestry carry the AF170 mutation. This may indicate that Crigler-Najjar syndrome type I in Sardinia is prevalent because of a founder effect. A similar effect has been previously detected for Crigler-Najjar syndrome type I in France, Portugal, Turkey, and Tunisia. 16 In six heterozygotes, all belonging to the same family, STB levels and promoter sequence variation were studied. Four of these have normal STB levels and absence of the promoter variation A(TA)7TAA. Normal STB concentration has to date been reported in subjects heterozygous for mutations that, most likely, cause absence of protein product or production of a shortened functionless protein.
Tetramers are thus assembled only from the normal subunits, probably resulting in 50% normal activity, which may be sufficient for bilirubin metabolism in normal conditions. This could be a reason for the normal STB values shown by these subjects. Two of the AF170 heterozygotes examined showed high STB levels (>40 gmol/l) and the presence of the sequence variation A(TA)7TAA in the heterozygous state. The sequence variation, although found in the heterozygous state, could explain the mild increase of STB concentration in these subjects. Recently it has been reported that a consistent decrease of the enzymatic activity of the UGT1A gene may also occur in those patients with Gilbert syndrome who are homozygous for the variant A(TA)7TAA
promoter.'2 The transfection of a construct containing the A(TA)7TAA promoter linked upstream to the firefly luciferase gene in a hepatic cell line led to a reduced luciferase expression, that is, 18 to 32% of that recorded in the presence of the normal TATA sequence motif (A(TA)6TAA). 
